Understanding and manipulating innate-like B cell mechanisms to prevent stroke associated Infection
- Funded by UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: C19-IUC-045
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
UK Research and Innovation (UKRI)Principal Investigator
Dr. Barry McCollResearch Location
United KingdomLead Research Institution
UK Dementia Research InstituteResearch Priority Alignment
N/A
Research Category
Clinical characterisation and managementResearch Subcategory
Prognostic factors for disease severitySpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Not applicableBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
Individuals with multimorbidity, OtherOccupations of Interest
Unspecified
Abstract
Amendment to an existing study - awaiting approval to add a COVID arm to MRC-funded stroke cohort that recently finished recruiting. This cohort has undergone deep immunophenotyping early after stroke to understand stroke-induced immune changes, infection risk, and associations with long-term outcome (including cognition). Project has potential implications for informing patient management prioritisation.